Chitosan film containing poly(D,L-Lactic-Co-Glycolic Acid) nanoparticles: A platform for localized dual-drug release

Pharmaceutical Research

Volumn 27, Issue 8, 2010, Pages 1738-1745

  Tada, Dayane B ^a   Singh, Surinder ^b   Nagesha, Dattatri ^a   Jost, Evan ^a   Levy, Craig O ^a   Gultepe, Evin ^a   Cormack, Robert ^c   Makrigiorgos, G Mike ^c   Sridhar, Srinivas ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

chitosan; drug release; implants coating; paclitaxel; PLGA

Indexed keywords

6 CARBOXYFLUORESCEIN; CHITOSAN; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; 6-CARBOXYFLUORESCEIN; FLUORESCEIN DERIVATIVE; GOLD; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; DEGRADATION; DRUG COATING; DRUG RELEASE; FILM; FLUORESCENCE; HYDROPHILICITY; LIGHT SCATTERING; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; SURFACE PROPERTY;

CHITOSAN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FLUORESCEINS; GOLD; HYDROPHOBICITY; LACTIC ACID; NANOPARTICLES; PACLITAXEL; POLYGLYCOLIC ACID; SURFACE PROPERTIES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS;

EID: 77955470132     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0176-9     Document Type: Article

References (25)

1. J Nunthanid S Puttipipatkhachorn K Yamamoto G Peck 2001 Physical properties and molecular behavior of chitosan films Drug Dev Ind Pharm 27 2 143 57 10.1081DDC100000481 10.1081/DDC-100000481 11266226 (Pubitemid 32207371)
2. J Xu SP McCarthy RA Gross 1996 Chitosan film acylation and effects on biodegradability Macromolecules 29 3436 40 10.1021/ma951638b 10.1021/ma951638b
3. T Freier HS Koh K Kazazian MS Shoichet 2005 Controlling cell adhesion and degradation of chitosan films by N-acetylation Biomaterials 26 5872 8 10.1016/j.biomaterials.2005.02.033 10.1016/j.biomaterials.2005.02.033 15949553 (Pubitemid 40798278)
4. G Cardenas P Anaya C von Plessing C Rojas J Sepulveda 2008 Chitosan composite films. Biomedical applications J Mater Sci Mater Med 19 2397 405 10.1007/s10856-007-3275-3 10.1007/s10856-007-3275-3 18165888
5. I Galeska T Kim SD Patil U Bhardwaj D Chatttopadhyay F Papadimitrakopoulos, et al. 2005 Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels AAPS J 7 1 E231 9 10.1208/aapsj070122 10.1208/aapsj070122 16146344 (Pubitemid 41554285)
6. SH Ranganath I Kee WB Krantz PK Chow C Wang 2009 Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order and implantability advantages for malignant brain tumour chemotherapy Pharm Res 26 9 2101 14 10.1007/s1109-009-9922-2 10.1007/s11095-009-9922-2 19543956
7. L Mu S Feng 2003 PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio Pharm Res 20 11 1864 72 10.1023/B:PHAM.0000003387.15428.42 10.1023/B:PHAM.0000003387.15428.42 14661934 (Pubitemid 37449463)
8. C Jin L Bai B Wu W Song G Guo K Dou 2009 Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells Pharm Res 2 7 1776 84 10.1007/s11095-009-9889-z 10.1007/s11095-009-9889-z
9. LE Van Vlerken Z Duan SR Little MV Seiden MM Amiji 2008 Biodistribution and pharmacokinetic analysis of palcitaxel and ceramide administred in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model Mol Pharm 5 4 516 26 10.1021/mp800030k 10.1021/mp800030k 18616278
10. WJ van der Giessen AM Lincoff RS Shwartz HMM van Beusekom PW Serruys DR Holmes, et al. 1996 Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 7 1690 7 8840862
11. U Westedt M Wittmar M Hellwig P Hanefeld A Greiner A Schaper, et al. 2006 Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft- poly(lactide-co-glycolide) and their potential as biodegradable stent coatings J Control Release 111 235 46 10.1016/j.conrel.2005.12.012 10.1016/j.jconrel.2005. 12.012 16466824
12. AW Heldman L Cheng GM Jenkins PF Heller DW Kim M Ware Jr, et al. 2001 Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis Circulation 103 2289 95 11342479
13. HM Garcia-Garcia S Vaina K Tsuchida PW Serruys 2006 Drug-eluting stents Arch Cardiol Méx 76 297 319 17091802
14. A Gershlick I De Scheerder B Chevalier A Stephens-Lloyd E Camenzind C Vrints, et al. 2004 Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation 109 487 93 10.1161/01.CIR.0000109694.58299.A0 10.1161/01.CIR.0000109694.58299.A0 14744971 (Pubitemid 38168511)
15. SC Dowdy S Jiang XC Zhou X Hou F Jin KC Podratz, et al. 2006 Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells Mol Cancer Ther 5 11 2767 76 10.1158/1535-7163.MCT-06-0209 10.1158/1535-7163.MCT-06- 0209 17121923 (Pubitemid 44849003)
16. DD Guo CX Xu JS Quan CK Song H Jin DD Kim, et al. 2009 Synersgistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo Biomaterials 30 477 4785 10.1016/jbiomaterials.2009.05.051
17. G Masters L Barreto E Girit M Jure-Kenkel 2009 Antitumor activity of cytotoxic T-lymphocyte antigen-4 blockade alone or combined with paclitaxel, etoposide, or gemcitabine in murine models J Immunother 32 9 994
18. RE Wurm F Gum S Erbel L Schlenger D Scheffler D Agaoglu, et al. 2006 Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience Acta Oncol 45 881 9 10.1080/02841860600919233 10.1080/02841860600919233 16982554 (Pubitemid 44423136)
19. Y Cui JG Dy GC Sharp B Alexander SB Jiang 2007 Multiple template-based fluoroscopic tracking of lung tumor mass without implanted fiducial markers Phys Med Biol 52 6229 42 10.1088/0031-9155/52/20/010 10.1088/0031-9155/52/20/010 17921582 (Pubitemid 350093191)
20. Y Cui JG Dy B Alexander SB Jiang 2008 Fluoroscopic gating without implanted fiducial markers for lung cancer radiotherapy based on support vector machines Phys Med Biol 53 N315 27 10.1088/0031-9155/53/16/N01 10.1088/0031-9155/53/16/N01 18660557
21. M Shirkhanzadeh 1998 Nanoporous alkoxy-derived titanium oxide coating: a reactive overlayer for functionalizing titanium surface J Mater Sci Mater Med 9 355 62 10.1023/A:1008859131585 10.1023/A:1008859131585 15348879 (Pubitemid 28291349)
22. E Gultepe D Nagesha L Menon A Busnaina S Sridhar 2007 High-throughput assembly of nanoelements in nanoporous alumina templates Appl Phys Lett 90 163119 10.1063/1.2730575 10.1063/1.2730575 (Pubitemid 46644870)
23. E Gultepe D Nagesha BDF Casse R Banyal T Fitchorov A Karma, et al. 2010 Sustained drug release from Non-eroding Nanoporous templates Small 6 2 213 6 10.1002/smll.200901736 10.1002/smll.200901736 19967712
24. Cormack R, Sridhar S, Suh W, D'Amico A, Makrigiorgos M. Biological in situ dose-painting for image-guided radiation therapy using drug-loaded implantable devices. Int J Radiat Oncol Biol Phys. 2009. doi: 10.1016/j.ijrobp.2009.06.039.
25. Y Fukumori H Ichikawa 2006 Nanoparticles for Cancer therapy and diagnosis Adv Powder Technol 17 1 1 28 10.1163/156855206775123494 10.1163/ 156855206775123494 (Pubitemid 43259046)